This inventor holds 1 USPTO granted patent. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique, Institut Curie. Active years: 2013.
Company Filing History:
1 out of 645 
1 out of 5,383 
1 out of 161 
Years Active: 2013
Title: Yasmin Ataman-Onal: Innovator in Colorectal Cancer Diagnosis
Introduction
Yasmin Ataman-Onal is a notable inventor based in Reyrieux, France. She has made significant contributions to the field of medical diagnostics, particularly in the early detection of colorectal cancer. Her innovative approach has the potential to improve patient outcomes through timely diagnosis.
Latest Patents
Yasmin holds a patent for the "Ezrin assay method for the in vitro diagnosis of colorectal cancer." This method involves determining the presence of the Ezrin tumor marker in a biological sample from patients suspected of having colorectal cancer. The technique utilizes at least one anti-Ezrin monoclonal antibody directed against specific Ezrin epitopes. This method is valuable for early diagnosis, screening, therapeutic follow-up, prognosis, and relapse diagnosis related to colorectal cancer. She has 1 patent to her name.
Career Highlights
Throughout her career, Yasmin has worked with prominent organizations such as bioMérieux, Inc. and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to develop and refine her innovative diagnostic methods.
Collaborations
Yasmin has collaborated with esteemed colleagues, including Monique Arpin and Corinne Beaulieu. These partnerships have contributed to her research and development efforts in the field of cancer diagnostics.
Conclusion
Yasmin Ataman-Onal is a pioneering inventor whose work in colorectal cancer diagnosis exemplifies the impact of innovation in healthcare. Her contributions are vital for advancing medical diagnostics and improving patient care.